These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2007-004716-31||Effects of growth hormone treatment after final height in Prader-Willi Syndrome: A double-blind multicenter, cross-over study on the effects of growth hormone versus placebo on body composition and ps...||bad-data|
|Ongoing||2011-001313-14||Young adult Prader-Willi Study||not-yet-due|
|Ongoing||2013-003100-39||Standardized versus individualized growth hormone treatment of short||not-yet-due|
|Completed, but no date||2013-004134-15||Intranasal administration of oxytocin in children and young adults with Prader-Willi Syndrome. A randomized, double-blind, placebo-controlled trial. Effects on satiety and food intake, and social beha...||bad-data|
|Other||2016-003820-22||Intranasal administration of oxytocin in children with Prader-Willi Syndrome. A randomized, open-label, cross-over trial of different treatment regimens of oxytocin administration. Effects on eating b...||not-yet-due|
|Ongoing||2017-003423-30||Randomized, double-blind, placebo-controlled oxytocin and dose-response trial in children with Prader-Willi syndrome. Effects on social behaviour.||not-yet-due|
|Ongoing||2018-004729-97||Randomized, controlled growth hormone study in children and adolescents with a Prader-Willi-like phenotype, followed by a two year open-label growth hormone study - effects on body composition, growth...||not-yet-due|